tiprankstipranks
PharmaCyte Biotech (PMCB)
NASDAQ:PMCB

PharmaCyte Biotech (PMCB) Ownership - Who Owns PharmaCyte Biotech?

210 Followers

PharmaCyte Biotech (PMCB) Ownership Overview

0.00%4.58%7.40%88.02%
0.00%
Insiders
7.40% Other Institutional Investors
88.02% Public Companies and
Individual Investors
The ownership structure of PharmaCyte Biotech (PMCB) stock is a mix of institutional, retail and individual investors. Approximately 11.98% of the company’s stock is owned by Institutional Investors, 0.00% is owned by Insiders and 88.02% is owned by Public Companies and Individual Investors.
The ownership structure of PharmaCyte Biotech (PMCB) stock is a mix of institutional, retail and individual investors. Approximately 11.98% of the company’s stock is owned by Institutional Investors, 0.00% is owned by Insiders and 88.02% is owned by Public Companies and Individual Investors.

Recent Hedge Fund Trading Activity

Currently, No Data Available
Date
Firm
Activity
Value

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
191,054Institution2.26%399,303
190,670Institution2.26%398,500
174,602Institution2.07%364,918
20,217Institution0.24%42,254
12,418Institution0.15%25,954
5,947Institution0.07%12,429
3,384Institution0.04%7,073
3,367Institution0.04%7,037
2Institution<0.01%4

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
190,670Institution2.26%398,500
174,602Institution2.07%364,918
12,418Institution0.15%25,954
5,947Institution0.07%12,429
3,367Institution0.04%7,037

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
116,135Institution1.37%227,625
74,919Institution0.89%146,841
11,506Institution0.14%23,357
8,707Institution0.10%18,198
3,384Institution0.04%7,073
4Institution<0.01%8

FAQ

Who Owns PharmaCyte Biotech (PMCB)?
According to the latest TipRanks data, approximately 7.40% of the company's stock is held by institutional investors, 0.00% is held by insiders, and 88.02% is held by retail investors.
    What percentage of PharmaCyte Biotech (PMCB) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 7.40% of PharmaCyte Biotech (PMCB) stock is held by institutional investors.
      What percentage of PharmaCyte Biotech (PMCB) stock is held by retail investors?
      According to the latest TipRanks data, approximately 88.02% of PharmaCyte Biotech (PMCB) stock is held by retail investors.
        Who owns the most shares of PharmaCyte Biotech (PMCB)?
        Vanguard owns the most shares of PharmaCyte Biotech (PMCB).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis